Literature DB >> 24272681

A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort.

Erica E M Moodie1, David A Stephens, Marina B Klein.   

Abstract

It is often the case that interest lies in the effect of an exposure on each of several distinct event types. For example, we are motivated to investigate in the impact of recent injection drug use on deaths due to each of cancer, end-stage liver disease, and overdose in the Canadian Co-infection Cohort (CCC). We develop a marginal structural model that permits estimation of cause-specific hazards in situations where more than one cause of death is of interest. Marginal structural models allow for the causal effect of treatment on outcome to be estimated using inverse-probability weighting under the assumption of no unmeasured confounding; these models are particularly useful in the presence of time-varying confounding variables, which may also mediate the effect of exposures. An asymptotic variance estimator is derived, and a cumulative incidence function estimator is given. We compare the performance of the proposed marginal structural model for multiple-outcome data to that of conventional competing risks models in simulated data and demonstrate the use of the proposed approach in the CCC.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; competing risks; confounding; failure-time data; intermediate variables; inverse-probability weighting; longitudinal data; marginal structural models; multiple-outcome data; simulation; survival analysis; time-dependent confounding

Mesh:

Year:  2013        PMID: 24272681     DOI: 10.1002/sim.6043

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

2.  Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.

Authors:  Mohammad Ehsanul Karim; John Petkau; Paul Gustafson; Robert W Platt; Helen Tremlett
Journal:  Stat Methods Med Res       Date:  2016-09-21       Impact factor: 3.021

3.  Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC Study.

Authors:  Alisa J Stephens-Shields; Andrew J Spieker; Amanda Anderson; Paul Drawz; Michael Fischer; Stephen M Sozio; Harold Feldman; Marshall Joffe; Wei Yang; Tom Greene
Journal:  Stat Med       Date:  2017-08-09       Impact factor: 2.373

4.  Inverse probability weighted estimation of risk under representative interventions in observational studies.

Authors:  Jessica G Young; Roger W Logan; James M Robins; Miguel A Hernán
Journal:  J Am Stat Assoc       Date:  2018-08-10       Impact factor: 5.033

5.  Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection.

Authors:  Zoe N Memel; Jenny J Lee; Andrea S Foulkes; Raymond T Chung; Tanayott Thaweethai; Patricia P Bloom
Journal:  medRxiv       Date:  2021-04-06

6.  Response to "Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician" by Tleyjeh et al.

Authors:  Martin Wolkewitz; Oksana Martinuka
Journal:  Open Forum Infect Dis       Date:  2021-12-03       Impact factor: 3.835

7.  Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Zoe N Memel; Jenny J Lee; Andrea S Foulkes; Raymond T Chung; Tanayott Thaweethai; Patricia P Bloom
Journal:  J Infect Dis       Date:  2022-01-05       Impact factor: 5.226

8.  Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality.

Authors:  Brittany M Bernardo; Robert C Orellana; Yiska Lowenberg Weisband; Niklas Hammar; Goran Walldius; Hakan Malmstrom; Anders Ahlbom; Maria Feychting; Judith Schwartzbaum
Journal:  Br J Cancer       Date:  2016-06-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.